{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:57:44Z","timestamp":1761544664603,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020515","name":"Federal Communications Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.japh.2023.05.007","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T12:31:01Z","timestamp":1683549061000},"page":"1203-1210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Versatile Prison Psychiatric Pharmacy Program"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-830X","authenticated-orcid":false,"given":"Neha N.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.japh.2023.05.007_bib1","first-page":"219","article-title":"Psychiatric pharmacy: new role of pharmacists in mental health","volume":"2","author":"Mohiuddin","year":"2019","journal-title":"Psychol Behav Sci"},{"issue":"3","key":"10.1016\/j.japh.2023.05.007_bib2","first-page":"106","article-title":"Mental health pharmacists: increasing necessary mental health service delivery","volume":"39","author":"Romney","year":"2022","journal-title":"Fed Pract"},{"issue":"4","key":"10.1016\/j.japh.2023.05.007_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1176\/appi.ps.670501","article-title":"Psychiatric pharmacists: key allies to improve antipsychotic metabolic monitoring","volume":"67","author":"Griebe","year":"2016","journal-title":"Psychiatr Serv"},{"issue":"3","key":"10.1016\/j.japh.2023.05.007_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0976-500X.114596","article-title":"Metabolic syndrome in schizophrenia: difference between antipsychotic-na\u00efve and treated patients","volume":"4","author":"Chadda","year":"2013","journal-title":"J\u00a0Pharmacol Pharmacother"},{"issue":"2","key":"10.1016\/j.japh.2023.05.007_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/YCO.0b013e32835035ca","article-title":"Life expectancy and cardiovascular mortality in persons with schizophrenia","volume":"25","author":"Laursen","year":"2012","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"10.1016\/j.japh.2023.05.007_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1078345819852044","article-title":"Clinical pharmacists in correctional facilities: a literature review and future directions","volume":"25","author":"Thomson","year":"2019","journal-title":"J\u00a0Correct Health Care"},{"issue":"8","key":"10.1016\/j.japh.2023.05.007_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.9740\/mhc.n95623","article-title":"Multifaceted correctional healthcare","volume":"1","author":"Nelson","year":"2012","journal-title":"Ment Health Clin"},{"year":"2011","series-title":"Electronic Medical Record (BEMR). [computer software]","author":"Bureau","key":"10.1016\/j.japh.2023.05.007_bib8"},{"key":"10.1016\/j.japh.2023.05.007_bib9","unstructured":"Facility Inmate Fact Sheet taken from US Federal Bureau of Prisons Butner FCC. Copyright. Cary, NC: SAS Institute Inc. 2014\u20132020. Reprinted With Permission. All Rights Reserved."},{"key":"10.1016\/j.japh.2023.05.007_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.876003","article-title":"Case report: long-acting oral cariprazine","volume":"13","author":"Dyrmishi","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.japh.2023.05.007_bib14","unstructured":"BOP Inmate Demographics taken from US Federal Bureau of Prisons Butner FCC. Copyright. Cary, NC: SAS Institute Inc. 2014\u20132020. Reprinted With Permission. All Rights Reserved."},{"issue":"5","key":"10.1016\/j.japh.2023.05.007_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamapsychiatry.2018.4320","article-title":"Association of antipsychotic polypharmacy vs monotherapy with psychiatric rehospitalization among adults with schizophrenia","volume":"76","author":"Tiihonen","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.japh.2023.05.007_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.20220446","article-title":"Safety of antipsychotic polypharmacy versus monotherapy in a nationwide cohort of 61,889 patients with schizophrenia","volume":"180","author":"Taipale","year":"2023","journal-title":"Am J Psychiatry"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123001474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123001474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:53:12Z","timestamp":1761544392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319123001474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1544319123001474"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2023.05.007","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Versatile Prison Psychiatric Pharmacy Program","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2023.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}